Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

BATS BZX Real-Time Price
As of 10:58am ET
 +0.74 / +0.60%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS-¤ US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Biotech ETF.


1 month-7.19% 3 years+2.69%
3 months-1.17% 5 years+18.24%
1 year+10.32% Since inception+23.69%
Data through 11/21/2017

Quote Details

Previous close$123.01
Open day’s range123.46 – 123.75
Net asset value (NAV)123.08 (11/20/2017)
Daily volume1,367
Average volume (3 months)26,779
Data as of 10:58am ET, 11/21/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.24%+16.79%
Expense Gross exp ratio0.40%1.33%
Risk 5 year sharpe ratio0.941.11
Net assets$657.3M$3.1B
Average market cap$31.0B$27.3B
Average P/E19.822.4
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen9.94%
GILD Gilead Sciences9.08%
CELG Celgene7.40%
BIIB Biogen5.69%
AGN Allergan5.53%
IQV Iqvia Holdings Inc5.44%
SHPG Shire5.03%
ILMN Illumina Inc4.84%
VRTX Vertex Pharmaceuticals Inc4.38%
BMRN Biomarin Pharmaceutical Inc4.35%